These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17521579)

  • 41. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice.
    Tanaka S; Saito Y; Kunisawa J; Kurashima Y; Wake T; Suzuki N; Shultz LD; Kiyono H; Ishikawa F
    J Immunol; 2012 Jun; 188(12):6145-55. PubMed ID: 22611244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A human immune system mouse model with robust lymph node development.
    Li Y; Masse-Ranson G; Garcia Z; Bruel T; Kök A; Strick-Marchand H; Jouvion G; Serafini N; Lim AI; Dusseaux M; Hieu T; Bourgade F; Toubert A; Finke D; Schwartz O; Bousso P; Mouquet H; Di Santo JP
    Nat Methods; 2018 Aug; 15(8):623-630. PubMed ID: 30065364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production.
    Yu H; Borsotti C; Schickel JN; Zhu S; Strowig T; Eynon EE; Frleta D; Gurer C; Murphy AJ; Yancopoulos GD; Meffre E; Manz MG; Flavell RA
    Blood; 2017 Feb; 129(8):959-969. PubMed ID: 28077418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.
    Jaiswal S; Pazoles P; Woda M; Shultz LD; Greiner DL; Brehm MA; Mathew A
    Immunology; 2012 Jul; 136(3):334-43. PubMed ID: 22384859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues.
    Waskow C; Liu K; Darrasse-Jèze G; Guermonprez P; Ginhoux F; Merad M; Shengelia T; Yao K; Nussenzweig M
    Nat Immunol; 2008 Jun; 9(6):676-83. PubMed ID: 18469816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
    Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
    Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
    Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL
    Clin Immunol; 2010 Apr; 135(1):84-98. PubMed ID: 20096637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advancing Human Vaccine Development Using Humanized Mouse Models.
    Han R; Su L; Cheng L
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse model.
    Saris J; Bootsma S; Verhoeff J; Tuynman JB; Wildenberg ME; Rijnstra ES; Lenos KJ; Garcia Vallejo JJ; Vermeulen L; Grootjans J
    Front Immunol; 2024; 15():1415457. PubMed ID: 39044825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cell development and antibody responses in human immune system mice: current status and future perspective.
    Zhang T; Liu W; Yang YG
    Sci China Life Sci; 2024 Apr; 67(4):645-652. PubMed ID: 38270770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.
    Gammelgaard OL; Terp MG; Kirkin AF; Johansen S; Traynor S; Vever H; Guldberg P; Kodahl AR; Gjerstorff MF; Ditzel HJ
    Mol Cancer; 2024 Jan; 23(1):6. PubMed ID: 38184565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection.
    Kim JT; Bresson-Tan G; Zack JA
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humanized MISTRG as a preclinical
    Martinez-Sanz P; Laurent ARG; Slot E; Hoogenboezem M; Bąbała N; van Bruggen R; Rongvaux A; Flavell RA; Tytgat GAM; Franke K; Matlung HL; Kuijpers TW; Amsen D; Karrich JJ
    Front Immunol; 2023; 14():1105103. PubMed ID: 36969261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
    Fereydouni M; Ahani E; Desai P; Motaghed M; Dellinger A; Metcalfe DD; Yin Y; Lee SH; Kafri T; Bhatt AP; Dellinger K; Kepley CL
    Front Oncol; 2022; 12():871390. PubMed ID: 35574362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The establishment and application of CD3E humanized mice in immunotherapy.
    Zhang R; Zhang J; Zhou X; Zhao A; Yu C
    Exp Anim; 2022 Nov; 71(4):442-450. PubMed ID: 35570001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current Status, Barriers, and Future Directions for Humanized Mouse Models to Evaluate Stem Cell-Based Islet Cell Transplant.
    Verhoeff K; Marfil-Garza BA; Cuesta-Gomez N; Jasra I; Dadheech N; Shapiro AMJ
    Adv Exp Med Biol; 2022; 1387():89-106. PubMed ID: 35362861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging insights in sarcoidosis: moving forward through reverse translational research.
    Liu A; Sharma L; Yan X; Dela Cruz CS; Herzog EL; Ryu C
    Am J Physiol Lung Cell Mol Physiol; 2022 Apr; 322(4):L518-L525. PubMed ID: 35196896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.
    Arnal-Estapé A; Foggetti G; Starrett JH; Nguyen DX; Politi K
    Cold Spring Harb Perspect Med; 2021 Dec; 11(12):. PubMed ID: 34518338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text]
    Kwon DH; Park JB; Lee JS; Kim SJ; Choi B; Lee KY
    Sci Rep; 2021 May; 11(1):10603. PubMed ID: 34011992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.
    Morris EC; Neelapu SS; Giavridis T; Sadelain M
    Nat Rev Immunol; 2022 Feb; 22(2):85-96. PubMed ID: 34002066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.